logo

For the Inventor, By the Inventor

Osaka, Japan

Toshikazu Hakogi

This inventor holds 10 USPTO granted patents and 5 EPO patents. Top assignees: Shionogi Company Limited, Viiv Healthcare Company, Glaxosmithkline LLC. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshikazu Hakogi. Retrieved from https://idiyas.com/inventor/toshikazu-hakogi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Hyogo, JP (2013 - 2014)
  • Osaka, JP (2012 - 2017)

Company Filing History:

goldMedal10 out of 1,001 
 
Shionogi Company Limited
 patents
silverMedal9 out of 42 
 
Viiv Healthcare Company
 patents
bronzeMedal1 out of 358 
 
Glaxosmithkline LLC
 patents
where one patent can have more than one assignee

Years Active: 2012-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9707246 - Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents (2017-07-18),
2. 9133216 - (3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-9 and/or (3S,11aR)-6-[(phenymethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-10 (2015-09-15),
3. 9012650 - Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agents (2015-04-21),
4. 8981129 - 2-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4 (2015-03-17),
5. 8940912 - 4-oxo-3-[(phenylmethyl)oxy]-4H-pyran-2-carboxylic acid (2015-01-27),
6. 8765965 - 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid of the formula P-6 and/or methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate of the formula P-7 (2014-07-01),
7. 8669362 - Processes and Intermediates for carbamoylpyridone HIV integrase inhibitors (2014-03-11),
8. 8580967 - Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof (2013-11-12),
9. 8552187 - Processes and intermediates for carbamoylpyridone HIV integrase inhibitors (2013-10-08),
10. 8217034 - Chemical compounds (2012-07-10),

Title: The Innovative Contributions of Toshikazu Hakogi

Introduction

Toshikazu Hakogi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating viral infections, including HIV. With a total of 10 patents to his name, Hakogi's work reflects a commitment to advancing healthcare through innovative solutions.

Latest Patents

Hakogi's latest patents include a series of compounds designed as HIV agents. One notable invention is the substituted (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides. This invention outlines a method for treating viral infections, particularly HIV, by administering specific compounds that have shown potential in combating the virus. Another significant patent involves intermediates in the preparation of therapeutic agents, specifically (3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione and its derivatives.

Career Highlights

Throughout his career, Hakogi has worked with notable companies such as Shionogi & Company Limited and ViiV Healthcare. His experience in these organizations has allowed him to collaborate on various projects aimed at developing effective treatments for viral infections. His dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Hakogi has collaborated with several professionals in his field, including Brian Alvin Johns and Jason Gordon Weatherhead. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Toshikazu Hakogi's contributions to medicinal chemistry and his innovative patents highlight his commitment to improving healthcare outcomes. His work in developing treatments for viral infections, particularly HIV, showcases the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…